SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-164200
Filing Date
2017-05-09
Accepted
2017-05-09 16:15:58
Documents
3
Period of Report
2017-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d390381d8k.htm 8-K 17242
2 EX-99.1 d390381dex991.htm EX-99.1 36134
3 GRAPHIC g390381g0509071618506.jpg GRAPHIC 4132
  Complete submission text file 0001193125-17-164200.txt   60359
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36644 | Film No.: 17826607
SIC: 2834 Pharmaceutical Preparations